Alembic Pharma gets USFDA nod for insomnia treatment drug

The company has got approval from the US Food and Drug Administration (USFDA) to market the drug in the strength of 7.5mg, 15mg, 22.5mg and 40mg, Alembic Pharmaceuticals said in a BSE filing.

from Moneycontrol Business News https://ift.tt/2DYPntF